Vivos Therapeutics, Inc.

Item 1C cybersecurity disclosure describing the registrant's risk management program, AI-based monitoring system, employee training, third-party diligence processes, and governance escalation framework. The filing explicitly states that, as of the date of the Report, no cybersecurity threats have materially affected or are reasonably likely to materially affect the company's business, operations, or financial condition. No incident is described.